Metabolic Markers of Attention Deficit Hyperactivity Disorder
- 专利权人:
- Laboratory Corporation of America Holdings
- 发明人:
- Ute Geigenmuller,Doris Damian,Maciej Pacula,Mark A. DePristo
- 申请号：
- US16713903
- 公开号：
- US20200188335A1
- 申请日:
- 2019.12.13
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- Disclosed herein are methods for treating subjects having ADHD identifiable by levels of 3-IS in blood.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Attention deficit / hyperactivity disorder model mouse, method for verifying the effect of preventing and alleviating concentration disorder using the model mouse, and method for treating concentration disorder by inhibiting T-type calcium channels
- ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
- Dérivés du benzodioxol pour leur utilisation dans le traitement du trouble du déficit de l'attention et/ou de l'hyperactivité
- PHARMACEUTICAL ASSOCIATION COMPOSITION FOR USE IN A METHOD FOR TREATING HYPERACTIVITY DISORDER WITH DEFICIT ATTENTION
- compound； guanfacine prodrug and its use； method for reducing gastrointestinal side effects associated with guanfacin therapy in a mammal； Methods of treating an attention deficit hyperactivity disorder and hypertension in a mammal
